ORLANDO, Fla., Aug. 2 /PRNewswire-FirstCall/ -- PainCare Holdings, Inc. , a leader in the delivery of orthopedic rehabilitation, minimally invasive spine surgery and pain management solutions, today reported that in the month of July, 2005, the Company expanded its network of affiliated and non-affiliated medical practices offering its proprietary ancillary service programs, bringing the total to 63 programs nationwide.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050329/NYTU045LOGO )
Specifically, PainCare signed contracts to deploy two EDX-Direct programs and one Intra Articular Joint (IAJ) program with independent physician practices in the month of July -- two located in Florida and one in Texas. In addition, the Company arranged for two EDX-Direct programs and three IAJ programs to be deployed at practices owned and/or managed by PainCare -- Associated Physicians Group, Colorado Pain Specialists, The Center for Pain Management, Pain & Rehabilitation Network and Pain Care Clinics.
As of July 31, 2005, PainCare is now under contract to manage a total of 63 MedX-Direct, EDX-Direct and IAJ programs with affiliated and non-affiliated practices located in 20 states throughout the country, which include Alabama, Arizona, Colorado, Florida, Georgia, Illinois, Louisiana, Maine, Maryland, Michigan, Missouri, North Carolina, North Dakota, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas and Virginia.
About EDX-Direct
Marketed by PainCare Holdings as EDX-Direct, this program provides for PainCare to supply contracted physician practices with all equipment, technical training and support necessary to introduce electro-diagnostic medicine into their respective practice care offerings. Physicians in the contracted EDX-Direct Program supply the necessary office space and manage all medical billing and collection activity.
Considered by many medical experts as one of the most accurate and objective methods of diagnosing the origin of pain in the neuromuscular system, electro-diagnostic medicine involves technical procedures (or nerve conduction studies) used to objectively assess the functional status of the peripheral neuromuscular system. When a nerve is stimulated electrically, a reaction occurs somewhere along the nerve. The reaction to this stimulation can be monitored and the time relationship between the stimulus and response can be displayed, measured and recorded. Measuring the electrical activity in nerves can help detect the presence, location and extent of diseases and injuries that damage nerves and result in recurring pain.
About Intra Articular Joint Program (IAJ Program)
PainCare’s IAJ Program is a proprietary, technologically advanced, non- operative knee treatment protocol that combines a five to six week series of strategically targeted injections of HYALGAN (pronounced HI-al-gan) -- the first FDA-approved hyaluronan therapy to treat OA knee pain in the United States, with synergistic orthopedic rehab procedures specifically designed to strengthen blood flow to the knee. Hyaluronan is found in many tissues throughout the body and is present in high concentrations in the joints. HYALGAN, developed and marketed by Sanofi-Aventis, is a sterile, highly purified mixture that is chemically similar to the hyaluronan found in the knee joint. When precisely injected into the knee’s joint space, HYALGAN bonds with joint fluid naturally present in the knee to create a lubricating and cushioning layer, thus reducing inflammation, swelling and prevailing pain and stiffness.
Under the IAJ Program, physicians inject HYALGAN directly into a patient’s knee under an advanced live motion x-ray unit (fluoroscopy) every 7-10 days until up to five injections have been administered. In addition, the patient executes a highly specialized physical therapy program based on a unique exercise algorithm created by PainCare to enhance strength and mobility of the knee.
About MedX-Direct Rehabilitation Program
Marketed as MedX-Direct Rehabilitation Program, PainCare is actively managing and operating programs with leading orthopedic surgeon, neuro- surgeon, physiatry and pain physician practices to provide the most advanced testing, strengthening and rehabilitation utilizing state-of-the-art MedX equipment installed on-site at each physician practice. In association with MedX Corporation, a manufacturer of industry leading testing, strengthening and rehabilitation equipment, PainCare’s MedX-Direct Rehabilitation Program is structured on a revenue sharing basis with each practice. To date, PainCare has deployed or is in the process of deploying Med-X Direct Programs throughout North America.
About PainCare Holdings, Inc.
Founded in Orlando, Florida in 2000, PainCare is rapidly emerging as one of North America’s leading providers of cost-effective, high-tech pain relief. The Company has established and is aggressively expanding a highly specialized, professional health services organization that is comprised of many internationally renowned neuro- and orthopedic surgeons, physiatrists and pain management specialists. Specifically, PainCare’s cadre of medical professionals offer pain sufferers a wide range of modalities including interventional pain management, minimally invasive spine surgery and orthopedic rehabilitation.
Through acquired or managed practices, and in partnership with independent physician practices, group practices and medical institutions throughout the country, PainCare also offers numerous ancillary services including MedX- Direct, a proprietary, on-site, turnkey orthopedic rehabilitation program; EDX-Direct, a comprehensive electro-diagnostic medicine program; diagnostic imaging services; Intra Articular Joint Program, a proprietary, non-operative treatment protocol for addressing knee pain and stiffness caused by osteoarthritis; and medical real estate services. In addition, the Company owns and operates five ambulatory surgery centers located in the southeast region of the United States.
For more information on PainCare Holdings, please visit http://www.paincareholdings.com.
This press release contains forward-looking statements that may be subject to various risks and uncertainties. Such forward-looking statements are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and are made based on management’s current expectations or beliefs as well as assumptions made by, and information currently available to, management. These forward-looking statements, which may include statements regarding our future financial performance or results of operations, including expected revenue growth, cash flow growth, future expenses, future operating margins and other future or expected performance, are subject to the following risks: the acquisition of businesses or the launch of new lines of business, which could increase operating expenses and dilute operating margins; the inability to attract new patients by our owned practices, the managed practices and the limited management practices; increased competition, which could lead to negative pressure on our pricing and the need for increased marketing; the inability to maintain, establish or renew relationships with physician practices, whether due to competition or other factors; the inability to comply with regulatory requirements governing our owned practices the managed practices and the limited management practices; that projected operating efficiencies will not be achieved due to implementation difficulties or contractual spending commitments that cannot be reduced; and to the general risks associated with our businesses.
In addition to the risks and uncertainties discussed above you can find additional information concerning risks and uncertainties that would cause actual results to differ materially from those projected or suggested in the forward-looking statements in the reports that we have filed with the Securities and Exchange Commission. The forward-looking statements contained in this press release represent our judgment as of the date of this release and you should not unduly rely on such statements. Unless otherwise required by law, we undertake no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise after the date of this press release. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in the filing may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT: Media Relations Mike Krutzler, Higher Advertising, Inc. at 407.447.1340 or via email at Mike@highadvertising.com Investor Relations Stephanie Noiseux, Elite Financial Communications Group, LLC at 407.585.1080 or via email at prz@efcg.net
Photo: http://www.newscom.com/cgi-bin/prnh/20050329/NYTU045LOGOPainCare Holdings, Inc.
CONTACT: Media Relations - Mike Krutzler of Higher Advertising, Inc.,+1-407-447-1340, Mike@highadvertising.com; or Investor Relations -Stephanie Noiseux of Elite Financial Communications Group, LLC,+1-407-585-1080, prz@efcg.net, both for PainCare Holdings, Inc.
Web site: http://www.paincareholdings.com/